MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
C2i Genomics, Inc.
Organization & Developments: C2i Genomics
Parents
C2i Genomics, Inc.
Children
2022: C2i Genomics snags European approval for blood test to detect residual cancer
2023: AstraZeneca extends C2i pact to validate minimal residual disease solid tumor blood test
2024: JPM 2024: Veracyte’s C2i Genomics Acquisition Adds AI Readouts to Liquid Biopsy Testing
Jumps
Finance & Acquisitions: C2i Genomics
Key People: C2i Genomics